Pathway Genomics: A New Contestant May 30, 2009
Posted by Dr. Bertalan Meskó in Genetic testing, Genome, Web 2.0.trackback
There already are plenty of companies offering direct-to-consumer genetic testing such as Navigenics, 23andMe, DecodeMe or Knome. Now, here is Pathway Genomics that aims to offer “the fastest, easiest and most secure DNA testing available, providing information that can save your life” for $249. Quite a brave mission statement, but the service seems to be promising.
You can order the test online, send your salive sample back and then they will share the genomic results of your sample with you through a secure form. You can get information about:
- Risk markers for 90+ diseases
- Maternal and paternal ancestry
- Drug responses including statins and warfarin.
- Carrier status (pre-pregnancy)
- Personal inheritable traits for eye color and back pain, among others.
Here they discuss privacy issues:
Further reading:
- Navigenics: What my genome tells me to do
- A Catalog of Published Genome-Wide Association Studies
- What is Pharmacogenomics?
- Navigenics: Customers speak
Advertisement
[...] Read the original here: Pathway Genomics: A New Contestant [...]
Did you notice Knome’s recent announcement that they’re now offering exome sequencing and interpretation for $19.5K? It’s hard to keep up!
[...] medicine, genetics. trackback After Navigenics, 23andMe, DecodeMe, Knome or the recently described Pathway Genomics, Illumine joins the direct-to-consumer genetic testing market. Illumina, Inc. today unveiled a [...]